| Literature DB >> 2228341 |
I De Lepeleire1, A Van Hecken, R Verbesselt, T B Tjandra-Maga, A Buntinx, L Distlerath, P J De Schepper.
Abstract
In eight healthy male volunteers taking daily subtherapeutic doses of warfarin (mean daily dose = 4.0 mg), the addition of famotidine 40 mg once-a-day for seven days did not alter the prothrombin time profile, thrombotest coagulation time or total warfarin steady-state plasma concentration. Plasma peak concentration, time to peak concentration and area under curve for famotidine were not affected by the co-administration of warfarin. However the plasma half-life of famotidine was slightly, but statistically significantly longer (p less than 0.05) during maintenance treatment with warfarin (mean +/- s.e.m.: 2.58 +/- 0.14 h versus 2.96 +/- 0.16 h respectively).Entities:
Mesh:
Substances:
Year: 1990 PMID: 2228341
Source DB: PubMed Journal: Int J Clin Pharmacol Res ISSN: 0251-1649